Sara K. Daniel
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Chemokine receptors and signaling
- CAR-T cell therapy research
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Venu G. Pillarisetty (8 shared papers)Yongwoo David Seo (4 shared papers)Kevin M. Sullivan (7 shared papers)Kevin P. Labadie (7 shared papers)James O. Park (6 shared papers)Raymond S. Yeung (6 shared papers)Xiuyun Jiang (4 shared papers)Kimberly S. Smythe (2 shared papers)
- Journals
- Scientific Reports (2 papers)Journal of Clinical Medicine (2 papers)Clinical Cancer Research (1 paper)The FASEB Journal (1 paper)Clinical Epigenetics (1 paper)
- Partner nations
- United StatesAustraliaDenmark
In The Last Decade
Sara K. Daniel
21 papers receiving 743 citations
Peers
Comparison fields: 5 of 71
- Oncology 326
- Immunology 202
- Cancer Research 125
- Hepatology 44
- Ophthalmology 28
Countries citing papers authored by Sara K. Daniel
This map shows the geographic impact of Sara K. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara K. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara K. Daniel more than expected).
Fields of papers citing papers by Sara K. Daniel
This network shows the impact of papers produced by Sara K. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara K. Daniel. The network helps show where Sara K. Daniel may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara K. Daniel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 185 | |
| 2 | 2019 | 175 | |
| 3 | 2019 | 167 | |
| 4 | 2014 | 35 | |
| 5 | 2018 | 33 | |
| 6 | 2012 | 32 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 24 | |
| 9 | 2021 | 15 | |
| 10 | 2023 | 13 | |
| 11 | 2019 | 9 | |
| 12 | 2018 | 9 | |
| 13 | 2012 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2019 | 2 | |
| 20 | 2012 | 2 |
About Sara K. Daniel
Sara K. Daniel is a scholar working on Oncology, Surgery, Immunology, Hepatology and Radiology, Nuclear Medicine and Imaging, having authored 21 papers that have together received 754 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Immunotherapy and Immune Responses (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Intraperitoneal and Appendiceal Malignancies (2 papers), Chemokine receptors and signaling (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (326 citations), Immunology (202 citations), Cancer Research (125 citations), Hepatology (44 citations) and Ophthalmology (28 citations). Sara K. Daniel has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Venu G. Pillarisetty, Yongwoo David Seo, Kevin M. Sullivan, Kevin P. Labadie, James O. Park, Raymond S. Yeung, Xiuyun Jiang, Kimberly S. Smythe, Seth M. Pollack and Florencia G. Jalikis. Their work appears in journals such as Scientific Reports, Journal of Clinical Medicine, Clinical Cancer Research, The FASEB Journal and Clinical Epigenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.